600285: Henan Lingrui Pharmaceutical Co., Ltd. - Summary | Jitta

Henan Lingrui Pharmaceutical Co., Ltd.

CHN:600285

Price
CN¥19.70
Loss Chance
41.5%
7.45JITTA SCORE
24.80%Under Jitta Line
Jitta Ranking
93 / 5,270
Grow your money with Jitta Ranking. See details.
HISTORICAL JITTA SCORE
Jitta Factors
Growth Opportunity (76)
Recent Business Performance (71)
Financial Strength (90)
Return to Shareholders (78)
Competitive Advantage (72)
Jitta Signs
Revenue and EarningConsistent Growth in the past 5 years
Operating MarginConsistent
Debt LevelLow Long Term Debt
Dividend PayoutIncreasing Every Year
CapExVery Low
SG&A to SalesDecreasing
Cash Conversion CycleMore than 120 days
Key Stats
Jitta Score
Jitta Line
7.45
24.80%
4.40
> 1,000%
4.23
> 1,000%
Pharmaceuticals
7.55
2.58%
5.63
16.32%
7.34
27.35%
COMPANY DESCRIPTION
Henan Lingrui Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of drugs in China. It operates through Medical and Healthcare Division; and Others segments. The company offers its products in ten dosage forms, such as adhesive plasters, tablets, capsules, granules, and tinctures, etc. for various indications, including orthopedic, cardiovascular, cerebrovascular, dermatology, pediatrics, respiratory, nutritional supplements, and anesthesiology. Its products include Tongluoqutong plasters, Peiyuantongnao capsules, Danlutongdu tablets, stomachache free tablets, and Shenqi Hypoglycemic capsules. The company also engages in industrial and real estate investment; technology research and development; ecological agriculture; and high-tech activities. Henan Lingrui Pharmaceutical Co., Ltd. was founded in 1992 and is headquartered in Xinyang, China.